Oncopeptides AB (publ) (STO:ONCO)
1.640
-0.051 (-3.02%)
Nov 20, 2026, 5:29 PM CET
Oncopeptides AB Market Cap
Oncopeptides AB has a market cap or net worth of 648.27 million as of November 20, 2026. It is the 27,774th most valuable company in the world and the 355th biggest in Sweden. Its market cap has decreased by 53.57% in one year.
Market Cap
648.27M
Enterprise Value
671.85M
Revenue
103.50M
Global Rank
Country Rank
#355 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since February 22, 2017, Oncopeptides AB's market cap has decreased from 1.67B to 648.27M, a decrease of -61.17%. That is a compound annual growth rate of -9.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 648.27M | -50.53% |
| Dec 30, 2025 | 1.31B | 291.35% |
| Dec 30, 2024 | 334.83M | -53.79% |
| Dec 29, 2023 | 724.64M | -36.76% |
| Dec 30, 2022 | 1.15B | 81.18% |
| Dec 30, 2021 | 632.45M | -94.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 22, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Flerie AB | 1.10B |
| Infant Bacterial Therapeutics AB | 956.47M |
| AlzeCure Pharma AB | 805.32M |
| SynAct Pharma AB | 734.70M |
| Medivir AB | 701.58M |
| Xspray Pharma AB | 496.93M |
| FluoGuide | 482.30M |
| Sprint Bioscience AB | 400.96M |